Reporting reimbursement price decisions for onco-hematology drugs in Spain

INTRODUCTION: Even using well-established technology assessment processes, the basis of the decisions on drug price and reimbursement are sometimes perceived as poorly informed and sometimes may be seen as disconnected from value. The literature remains inconclusive about how Health Technology Asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Elvira, David, Torres, Ferran, Vives, Roser, Puig, Gemma, Obach, Mercè, Gay, Daniel, Varón, Daniel, de Pando, Thais, Tabernero, Josep, Pontes, Caridad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627880/
https://www.ncbi.nlm.nih.gov/pubmed/37942255
http://dx.doi.org/10.3389/fpubh.2023.1265323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627880/
https://www.ncbi.nlm.nih.gov/pubmed/37942255
http://dx.doi.org/10.3389/fpubh.2023.1265323

Ejemplares similares